Contact |
You are now leaving the Averitas Pharma, Inc. website and will be redirected to a site intended for an international audience. Please be aware that the content, products, and services on the international site may differ from those on our U.S. site and may not be approved for a U.S. audience.
Click "Continue" if you wish to proceed to the international site, or "Cancel" to stay on the current page.
We are proudly building upon the 75-year legacy of Grünenthal by bringing innovative pain medicines to a growing group of patients in the United States.
Come see how drawing on our collective strengths helps us deliver on our ambitious goals.
Learn MoreYou are now leaving the Averitas Pharma, Inc. website and will be redirected to a site intended for an international audience. Please be aware that the content, products, and services on the international site may differ from those on our U.S. site and may not be approved for a U.S. audience.
Click "Continue" if you wish to proceed to the international site, or "Cancel" to stay on the current page.
We are proudly building on the 75-year legacy of Grünenthal, a global privately held healthcare company that has been working tirelessly toward a world free of pain by approaching pain as a disease in urgent need of a solution, rather than a mere symptom.